The FDA should decline to enforce a mifepristone ban, argue Dean Rebouche and co-authors David S. Cohen and Greer Donley in this Guardian op-ed.
Published on May 3, 2023
To protect abortion access, the FDA should decline to enforce a mifepristone ban
